保险、城乡与共病和头颈癌患者接受不同类型姑息治疗的相关性
本研究基于美国国家癌症数据库 2016 年数据,回顾性分析头颈癌患者中与仅接受疼痛姑息治疗(而非手术、化疗或放疗等细胞减灭性姑息治疗)相关的社会与医学因素。多因素逻辑回归显示,保险状态、城乡分布及 Charlson-Deyo 评分大于 3 与仅接受疼痛姑息治疗显著相关。作者提示临床医生应关注保险状态等非健康因素对治疗选择的影响。
要点
- 保险状态、城乡分布和 Charlson-Deyo 评分大于 3 与头颈癌患者仅接受疼痛姑息治疗独立相关。
- 研究提示非健康相关因素如保险状态可能影响头颈癌患者的治疗接受情况。
- 临床医生应意识到社会因素在头颈癌姑息治疗决策中的潜在作用。
核心结论
- 保险状态、城乡分布及 Charlson-Deyo 评分大于 3 与头颈癌患者仅接受疼痛姑息治疗而非细胞减灭性姑息治疗显著相关。
- 临床医生应关注保险状态等非健康相关因素对头颈癌患者治疗接受的影响。
研究设计与样本
- 回顾性研究,使用美国国家癌症数据库 2016 年数据。
- 采用双变量分析和逻辑回归分析患者及肿瘤特征与仅接受疼痛姑息治疗 vs 细胞减灭性姑息治疗的关联。
主要发现
- 多因素逻辑回归显示,保险状态与仅接受疼痛姑息治疗相关(OR:0.27,95%CI:0.15-0.50,p < 0.001)。
- 城乡分布与仅接受疼痛姑息治疗相关(OR:1.73,95%CI:1.21-2.46,p = 0.002)。
- Charlson-Deyo 评分大于 3 与仅接受疼痛姑息治疗相关(OR:2.49,95%CI:1.38-4.47,p = 0.002)。
临床怎么用
- 在头颈癌姑息治疗决策中,除临床因素外,应关注保险状态、城乡分布等社会因素对治疗选择的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Our study examined some of the social and medical factors associated with receiving pain palliation alone over more aggressive cytoreductive palliative measures, such as surgery, chemotherapy, or radiation among patients with head and neck cancer. METHODS: This retrospective study used the National Cancer Database 2016 for data analysis. Patient and tumor characteristics were examined using bivariate analysis and logistic regression to identify their association with receiving pain palliation alone versus cytoreductive palliation treatment. RESULTS: Using multivariate logistic regression analysis, insurance status (odds ratio [OR]: 0.27, 95% confidence interval [CI]: 0.15-0.50, p < 0.001), urbanity (OR: 1.73, 95%CI: 1.21-2.46, p = 0.002), and Charlson-Deyo scores greater than 3 (OR: 2.49, 95%CI: 1.38-4.47, p = 0.002) were significantly associated with receipt of pain palliation alone. CONCLUSIONS: Clinicians should be aware of non-health-related factors, such as insurance status, that may influence patients' receipt of treatments in head and neck cancer.
引用
- Ramsey T, Lee B, Curran K, et al. Associations of insurance, urbanity, and comorbidity with types of palliative care received by patients with head and neck cancer. Head Neck. 2021. PMID: 33599358. doi:10.1002/hed.26648
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。